BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1675299)

  • 1. Absence of allelic loss on chromosome 5q by RFLP analysis in preleukemia.
    Shepherd L; Cameron C; Galbraith P; Windsor S; Lillicrap D
    Leuk Res; 1991; 15(5):297-303. PubMed ID: 1675299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical picture and molecular disorders in myelodysplastic (MDP) syndromes].
    Rupniewska ZM
    Pol Arch Med Wewn; 1992 Mar; 87(3):197-208. PubMed ID: 1523148
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukemic transformation in patients with the 5q- alteration: analysis of the behavior of the 5q- clones in preleukemic to leukemic phases.
    Benitez J; Martinez Frejo C; Toledo C; Sanchez Fayos J; Ramos C
    Cancer Genet Cytogenet; 1987 Jun; 26(2):199-207. PubMed ID: 3567873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion.
    Boultwood J; Rack K; Kelly S; Madden J; Sakaguchi AY; Wang LM; Oscier DG; Buckle VJ; Wainscoat JS
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6176-80. PubMed ID: 1829836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of chromosome 7 long arm deletions in myeloid disorders.
    Kere J; Ruutu T; Lahtinen R; de la Chapelle A
    Blood; 1987 Nov; 70(5):1349-53. PubMed ID: 2889483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome abnormalities in bone marrow of Fanconi anemia patients.
    Berger R; Le Coniat M; Schaison G
    Cancer Genet Cytogenet; 1993 Jan; 65(1):47-50. PubMed ID: 8431915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic analysis in patients with myelodysplastic syndrome.
    Hu N; Bian M
    Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(3):135-9. PubMed ID: 2098765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C/EBP-epsilon: chromosomal mapping and mutational analysis of the gene in leukemia and preleukemia.
    Koike M; Chumakov AM; Takeuchi S; Tasaka T; Yang R; Nakamaki T; Tsuruoka N; Koeffler HP
    Leuk Res; 1997 Sep; 21(9):833-9. PubMed ID: 9393598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trisomy 4 and ring chromosome in a patient with acute myelomonocytic leukemia.
    Vicari L; Sebastio L; Stanziola MC; Fasanaro A; Ferrara F
    Haematologica; 1994; 79(1):83-5. PubMed ID: 15378955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders.
    Neuman WL; Rubin CM; Rios RB; Larson RA; Le Beau MM; Rowley JD; Vardiman JW; Schwartz JL; Farber RA
    Blood; 1992 Mar; 79(6):1501-10. PubMed ID: 1347709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic abnormalities in the myelodysplastic syndrome.
    Jacobs A
    Acta Haematol Pol; 1991; 22(2):197-202. PubMed ID: 1841492
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytogenetics of childhood preleukemia.
    Nowell P; Wilmoth D; Lange B
    Cancer Genet Cytogenet; 1983 Nov; 10(3):261-6. PubMed ID: 6627223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelodysplastic syndrome associated with isolated del (5q) chromosome abnormality ("5q- syndrome").
    Maslak P
    Blood; 2007 Dec; 110(12):3825. PubMed ID: 18062093
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic lesions in preleukemia.
    Carter G; Ridge S; Padua RA
    Crit Rev Oncog; 1992; 3(4):339-64. PubMed ID: 1420444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Megakaryocytopoiesis in patients with myelodysplastic syndromes (MDS) with and without del(5q).
    Podolak-Dawidziak M; Geddes D; Bowen D
    Eur J Haematol; 1990 Aug; 45(2):115-6. PubMed ID: 2271049
    [No Abstract]   [Full Text] [Related]  

  • 16. Multilineage involvement in the 5q- syndrome: a fluorescent in situ hybridization study on bone marrow smears.
    Bigoni R; Cuneo A; Milani R; Cavazzini F; Bardi A; Roberti MG; Agostini P; della Porta M; Specchia G; Rigolin GM; Castoldi G
    Haematologica; 2001 Apr; 86(4):375-81. PubMed ID: 11325642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular definition of chromosome arm 5q deletion end points and detection of hidden aberrations in patients with myelodysplastic syndromes and isolated del(5q) using oligonucleotide array CGH.
    Evers C; Beier M; Poelitz A; Hildebrandt B; Servan K; Drechsler M; Germing U; Royer HD; Royer-Pokora B
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1119-28. PubMed ID: 17823930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic abnormalities in myelodysplastic syndrome.
    Jacobs A
    Cancer Genet Cytogenet; 1991 Oct; 56(1):1-6. PubMed ID: 1747865
    [No Abstract]   [Full Text] [Related]  

  • 19. [Myelodysplastic syndromes: preleukemic syndromes].
    Tassin F; Hermanne JP; Schaaf-Lafontaine N; Herens C; Thiry A; Paulus JM; Boniver J; Fillet G
    Rev Med Liege; 1998 Jun; 53(6):357-62. PubMed ID: 9713217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome 7 long arm deletion breakpoints in preleukemia: mapping by pulsed field gel electrophoresis.
    Kere J
    Nucleic Acids Res; 1989 Feb; 17(4):1511-20. PubMed ID: 2922284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.